University Hospital Liège
Welcome,         Profile    Billing    Logout  
 24 Trials 
27 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
CARPENTIER, Alexandre
StrateGlio, NCT03663725 / 2018-000410-38: Treatment Intensification With Temozolomide in Adults With a Glioblastoma

Recruiting
3
486
Europe
Intensified protocol, Stupp protocol
Centre Oscar Lambret, Association de Neuro-Oncologues d'Expression Francaise, Erasme University Hospital
Glioblastoma
05/25
11/27
Beguin, Yves
TRACE, NCT04832607 / 2018-000853-29: Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections

Recruiting
3
149
Europe
Multivirus (CMV, EBV, AdV)-specific T cells
Prof. Tobias Feuchtinger, European Commission, Simbec-Orion Group Ltd, Merthyr Tydfil, UK, Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany, Leiden University Medical Center, LUMC, Leiden, The Netherlands, Centre Hospitalier Universitaire de Nancy, CHU, Vandoeuvre-Lès-Nancy, France, Ghent University Hospital, UZG, Ghent, Belgium, Ospedale Pediatrico Bambino Gesù, OPBG, Rome, Italy, Newcastle University, UNEW, Newcastle, UK, Vall d'Hebron Institute of Oncology (VHIO) and Banc de Sang I Teixits (BST), Barcelona, Spain
AdV Infection, EBV Infection, CMV Infection, Stem Cell Transplant Complications
06/24
12/24
Predictor2, NCT03887156: Evaluation of a Donor Testing Kit for the Prediction of AGVHD in Patient Receiving a Peripheral Blood Stem Cell Allograft

Recruiting
2/3
227
Europe
Ex vivo capacities of CD4neg INkT expansion of the peripheral blood donor with the Predictor test
Assistance Publique - Hôpitaux de Paris, SATT, SNC Graft Versus Host Disease, Imagine Institute, Axonal-Biostatem, CERBA laboratory
Acute Myeloid Leukemia in Remission, Lymphoma in Remission, Non-progressive Myeloproliferative Syndrome, Myelodysplasia With Stable Blasts is Cell Number and < 10% of Blastocysts, Acute Leukemia Biphenotypic in Remission, Acute Lymphoblastic Leukemia
03/23
03/23
NCT03083574: Extracorporeal Photopheresis Using Theraflex ECP™ for Patients With Refractory Chronic Graft Versus Host Disease (cGVHD)

Recruiting
2
100
Europe
Photopheresis Theraflex ECP™
Jules Bordet Institute, Macopharma, Belgian Hematological Society
Refractory Chronic Graft Versus Host Disease (cGVHD)
09/22
09/23
NCT00603330: Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function

Recruiting
2
100
Europe
Mesenchymal stem cells
University of Liege, KU Leuven, Maastricht University Medical Center, Ziekenhuis Netwerk Antwerpen (ZNA), University Hospital, Antwerp, University Hospital, Ghent, AZ-VUB, AZ Sint-Jan AV, Cliniques universitaires Saint-Luc- Université Catholique de Louvain, University Hospital of Mont-Godinne, Jolimont Hospital Haine Saint Paul, Queen Fabiola Children's University Hospital
Graft-versus-host Disease, Poor Graft Function, Low Donor T-cell Chimerism
08/24
08/24
NCT04445454: Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection

Recruiting
1/2
20
Europe
Mesenchymal stromal cells, MSC
University of Liege
Coronavirus Infection
09/24
09/24
CYCLE-1, NCT04167696: Study in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Patients to Determine the Recommended Dose of CYAD-02

Recruiting
1
27
Europe, US
CYAD-02, ENDOXAN, cyclophosphamide, Fludara, fludarabine
Celyad Oncology SA
Acute Myeloid Leukemia, Myelodysplastic Syndrome
12/21
02/35
Lechanteur, Chantal
NCT00603330: Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function

Recruiting
2
100
Europe
Mesenchymal stem cells
University of Liege, KU Leuven, Maastricht University Medical Center, Ziekenhuis Netwerk Antwerpen (ZNA), University Hospital, Antwerp, University Hospital, Ghent, AZ-VUB, AZ Sint-Jan AV, Cliniques universitaires Saint-Luc- Université Catholique de Louvain, University Hospital of Mont-Godinne, Jolimont Hospital Haine Saint Paul, Queen Fabiola Children's University Hospital
Graft-versus-host Disease, Poor Graft Function, Low Donor T-cell Chimerism
08/24
08/24
Baudoux, Etienne
NCT00603330: Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function

Recruiting
2
100
Europe
Mesenchymal stem cells
University of Liege, KU Leuven, Maastricht University Medical Center, Ziekenhuis Netwerk Antwerpen (ZNA), University Hospital, Antwerp, University Hospital, Ghent, AZ-VUB, AZ Sint-Jan AV, Cliniques universitaires Saint-Luc- Université Catholique de Louvain, University Hospital of Mont-Godinne, Jolimont Hospital Haine Saint Paul, Queen Fabiola Children's University Hospital
Graft-versus-host Disease, Poor Graft Function, Low Donor T-cell Chimerism
08/24
08/24
Willems, Evelyne
ARES, NCT04769895 / 2021-001841-11: MaaT013 As Salvage Therapy in Ruxolitinib Refractory GI-aGVHD Patients

Active, not recruiting
3
66
Europe
MaaT013
MaaT Pharma, MaaT Pharma
Acute Graft Versus Host Disease in Intestine, Steroid Refractory GVHD
11/24
11/25
ROCKnrol-1, NCT06143891: A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease.

Recruiting
3
260
Europe, Canada, US, RoW
Belumosudil, SAR445761/ KD025, REZUROCK, Placebo, Prednisone, Prednisolone
Sanofi
Chronic Graft Versus Host Disease
09/28
09/28
SCRIPT-AML, NCT05477589: Studying Conditioning Regimen In Pediatric Transplantation - AML ,

Recruiting
3
170
Europe, RoW
busulfan, cyclophosphamide and melphalan, BuCyMel, BuCyMel, clofarabine, fludarabine and busulfan, CloFluBu, CloFluBu
Vastra Gotaland Region
Acute Myeloid Leukemia (AML) in Remission, Stem Cell Transplantation
12/29
12/31
NCT03083574: Extracorporeal Photopheresis Using Theraflex ECP™ for Patients With Refractory Chronic Graft Versus Host Disease (cGVHD)

Recruiting
2
100
Europe
Photopheresis Theraflex ECP™
Jules Bordet Institute, Macopharma, Belgian Hematological Society
Refractory Chronic Graft Versus Host Disease (cGVHD)
09/22
09/23
NCT00603330: Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function

Recruiting
2
100
Europe
Mesenchymal stem cells
University of Liege, KU Leuven, Maastricht University Medical Center, Ziekenhuis Netwerk Antwerpen (ZNA), University Hospital, Antwerp, University Hospital, Ghent, AZ-VUB, AZ Sint-Jan AV, Cliniques universitaires Saint-Luc- Université Catholique de Louvain, University Hospital of Mont-Godinne, Jolimont Hospital Haine Saint Paul, Queen Fabiola Children's University Hospital
Graft-versus-host Disease, Poor Graft Function, Low Donor T-cell Chimerism
08/24
08/24
NCT03852407: Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning

Recruiting
2
114
Europe
Thymoglobulin, ATG, Melphalan, alkeran, Fludarabine, Cyclophosphamid, PTCy
University of Liege, Belgian Hematological Society
Acute Myeloid Leukemia in Remission, Myelodysplastic Syndromes, Chronic Myeloid Leukemia in Remission, Myeloproliferative Syndrome, Myeloproliferative Disorder, Acute Lymphoid Leukemia in Remission, Multiple Myeloma, Chronic Lymphoid Leukemia, Non Hodgkin Lymphoma, Hodgkin Lymphoma
11/33
11/38
Baron, Frédéric
NCT04951323: Impact of the Immune System on Response to Anti-Coronavirus Disease 19 (COVID-19) Vaccine in Allogeneic Stem Cell Recipients (Covid Vaccin Allo)

Recruiting
3
50
Europe
anti-COVID19 mRNA-based vaccine (BNT162b2, Comirnaty®, commercialized by Pfizer), COVID-19 mRNA Vaccine, Pfizer
University of Liege, Pfizer
Coronavirus Disease 2019 (Covid19), Hematopoietic Neoplasms
12/22
01/23
Predictor2, NCT03887156: Evaluation of a Donor Testing Kit for the Prediction of AGVHD in Patient Receiving a Peripheral Blood Stem Cell Allograft

Recruiting
2/3
227
Europe
Ex vivo capacities of CD4neg INkT expansion of the peripheral blood donor with the Predictor test
Assistance Publique - Hôpitaux de Paris, SATT, SNC Graft Versus Host Disease, Imagine Institute, Axonal-Biostatem, CERBA laboratory
Acute Myeloid Leukemia in Remission, Lymphoma in Remission, Non-progressive Myeloproliferative Syndrome, Myelodysplasia With Stable Blasts is Cell Number and < 10% of Blastocysts, Acute Leukemia Biphenotypic in Remission, Acute Lymphoblastic Leukemia
03/23
03/23
NCT00603330: Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function

Recruiting
2
100
Europe
Mesenchymal stem cells
University of Liege, KU Leuven, Maastricht University Medical Center, Ziekenhuis Netwerk Antwerpen (ZNA), University Hospital, Antwerp, University Hospital, Ghent, AZ-VUB, AZ Sint-Jan AV, Cliniques universitaires Saint-Luc- Université Catholique de Louvain, University Hospital of Mont-Godinne, Jolimont Hospital Haine Saint Paul, Queen Fabiola Children's University Hospital
Graft-versus-host Disease, Poor Graft Function, Low Donor T-cell Chimerism
08/24
08/24
NCT01428973 / 2010-024297-19: Minitransplants With HLA-matched Donors : Comparison Between 2 GVHD Prophylaxis Regimens

Active, not recruiting
2
200
Europe
Mycophenolate mofetil, CellCept, Sirolimus, Rapamune
University of Liege, AZ Sint-Jan AV, Ziekenhuis Netwerk Antwerpen (ZNA), Jules Bordet Institute, University Hospital, Gasthuisberg, AZ-VUB, Cliniques universitaires Saint-Luc- Université Catholique de Louvain, University Hospital, Antwerp, Cliniques Universitaires de Mont-Godinne, Hospital de Jolimont, University Hospital, Ghent, AZ Delta
Graft-Versus-Host Disease, Hematological Malignancies
12/24
12/24
NCT03852407: Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning

Recruiting
2
114
Europe
Thymoglobulin, ATG, Melphalan, alkeran, Fludarabine, Cyclophosphamid, PTCy
University of Liege, Belgian Hematological Society
Acute Myeloid Leukemia in Remission, Myelodysplastic Syndromes, Chronic Myeloid Leukemia in Remission, Myeloproliferative Syndrome, Myeloproliferative Disorder, Acute Lymphoid Leukemia in Remission, Multiple Myeloma, Chronic Lymphoid Leukemia, Non Hodgkin Lymphoma, Hodgkin Lymphoma
11/33
11/38
1621-QLG-LG, NCT03755856: Long-term Outcomes for Acute Myeloid Leukemia Patients

Recruiting
N/A
343
Europe, RoW
Questionnaire
Gruppo Italiano Malattie EMatologiche dell'Adulto, European Organisation for Research and Treatment of Cancer - EORTC
Acute Myeloid Leukemia
06/21
12/22
Louis, Edouard
TARGET, NCT02425865: Intensive Treatment to Reach the Target With Golimumab in ulcErative coliTis - In-

Completed
4
202
Europe
GOLIMUMAB
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
ULCERATIVE COLITIS
10/21
01/23
FREE, NCT04646187 / 2020-001811-26: De-escalation of Anti-TNF Therapy in Inflammatory Bowel Disease

Enrolling by invitation
4
148
Europe
Infliximab, Remicade, Flixabi, Inflectra, Remsima, Zessly, Adalimumab, Humira, AMGEVITA, Hulio, Hyrimoz, Idacio, Imraldi
University Medical Center Groningen, European Crohn´s and Colitis Organisation, Bühlmann Laboratories AG
Inflammatory Bowel Diseases, Crohn Disease, Colitis, Ulcerative
03/26
03/26
SOPRANO-CD, NCT05169593: Prevention of Postoperative Endoscopic Recurrence with Endoscopy-driven Versus Systematic Biological Therapy

Recruiting
4
292
Europe
Biological Drug, Risankizumab, Vedolizumab, Ustekinumab, Infliximab, Adalimumab
Universitaire Ziekenhuizen KU Leuven
Crohn Disease
10/27
10/30
SOCRATES, NCT04089345: Stelara fOr ChRonic AntibioTic rEfractory pouchitiS

Completed
3
20
Europe
Ustekinumab, Stelara
Universitaire Ziekenhuizen KU Leuven, Janssen Pharmaceuticals
Pouchitis
12/22
05/23
NCT03901235: MSC Intratissular Injection in Crohn Disease Patients

Recruiting
1/2
60
Europe
Mesenchymal Stromal Cells
University of Liege, Centre Hospitalier Universitaire de Liege
Efficacy and Safety
12/25
12/26
POP-REMIND, NCT03458195: Ileal Crohn's Disease and Post-operative Outcome: Prospective Cohort Study of the REMIND Group

Recruiting
N/A
575
Europe
bio-banking collection
Saint-Louis Hospital, Paris, France
Crohn Disease
12/25
12/26
Humblet-Baron, Stéphanie
No trials found
Hannon, Muriel
No trials found
Malaise, Olivier
No trials found

Download Options